entertainment -WSS

entertainment

author：entertainment 2025-09-03 22:13:06 - browse：7794

Medicare generally pays far more for CAR-T drugs that are administered in outpatient departments than it does for inpatient care. Adobe

WASHINGTON — Hospitals for years have complained that Medicare pays so little for CAR-T cancer treatments that they sometimes lose money administering the incredibly expensive treatments. But that could soon change: if drug companies succeed in making the cancer treatments safer, hospitals could provide them more often in outpatient departments, where payment is higher.

CAR-T uses the body’s own immune system to kill cancerous cells. The procedure, regulated as a drug, involves taking T cells from a patient’s blood, adding chimeric antigen receptors (CAR) to the T cells that kill cancer, and injecting the CAR-T treatment back into the patient.

It’s worked wonders in many cancer patients who have run out of options. But right now it’s almost exclusively administered in hospitals, because the side effects can require aggressive treatments. In many cases, the CAR-T cells trigger immune reactions that can be life-threatening.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Affirmative action in medical school literally saved lives
Next article： When prostate cancer spreads, where it goes matters

WSS

Readout Newsletter: Nvidia, Biogen, Ionis, AstraZeneca, ChatGPT

Pope Francis asks Church to identify 21st

Microsoft's Peter Lee says ChatGPT shouldn't be used for initial diagnosis

Suspect in Ukraine detonates explosives at a courthouse, killing himself and wounding 2 officers

EU moves toward latest gene techniques in food production to counter climate change, shortages

Arc Institute generative AI designs new CRISPR systems

knowledge

entertainment

focus

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Condition critical? Britain's beloved but battered National Health Service turns 75

Apple is now the first public company to be valued at $3 trillion

EU moves toward latest gene techniques in food production to counter climate change, shortages

United colonoscopy coverage change 'may cost lives,' doctors say

How a billionaire couple greased the skids for Pelosi’s drug pricing bill

Walensky prepares to leave CDC — and Congress — behind

Arc Institute generative AI designs new CRISPR systems

Apple is now the first public company to be valued at $3 trillion

Search warrant issued in 1996 disappearance of Kristin Smart

Wikipedia

Readout Newsletter: Nvidia, Biogen, Ionis, AstraZeneca, ChatGPT

It's time to retire 'poor historian' from clinicians' vocabularies

3 protesters arrested at Wimbledon after interrupting matches by throwing confetti on court

Supreme Court shows surprising restraint in chaotic year of crises: ANALYSIS

With measles on the rise, a personal story of a devastating disease

Man pleads guilty to raping Ohio girl who ended up traveling across state lines for abortion

hotspot

explore

Wikipedia

Wikipedia